Internal Medicine · Waipahu, HI
NPI
1548349590
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
94-307 Farrington Hwy, A5
Waipahu, HI, 96797
Phone (808) 671-1634
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,988
74 services
Medicare patients, 2024
29
Average age 75
Drug cost, 2024
$899K
5,068 prescriptions
Company payments, 2025
$1,893
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rosalo M Paeste was code 99214 (office e&m - established), 43 times for 27 patients. In total Rosalo M Paeste billed 74 services in 4 codes, and Medicare paid $4,988.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 43 | 27 | $51.59 | $2,218 |
By year: 2022 $8,482 for 124 services; 2023 $9,213 for 120 services; 2024 $4,988 for 74 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rosalo M Paeste prescribed most often to Medicare patients was Atorvastatin Calcium, with 323 prescriptions and refills. In total Rosalo M Paeste wrote 5,068 Medicare prescriptions that cost $899K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 323 | 953 | 100 | $6,742 |
| Amlodipine Besylate Generic | 232 | 679 | 71 | $2,197 |
| Losartan Potassium Generic | 174 | 535 | 56 | $2,413 |
| Metoprolol Succinate Generic | 131 | 389 | 40 | $3,233 |
| Rosuvastatin Calcium Generic | 130 | 400 | 43 | $4,046 |
| Allopurinol Generic | 113 | 343 | 36 | $1,195 |
| Pravastatin Sodium Generic | 98 | 308 | 29 | $1,613 |
| Farxiga Dapagliflozin Propanediol | 92 | 195 | 24 | $104K |
| Raloxifene Hcl Generic | 90 | 255 | 24 | $7,402 |
| Famotidine Generic | 86 | 239 | 33 | $1,544 |
| Pioglitazone Hcl Generic | 82 | 245 | 25 | $1,637 |
| Levothyroxine Sodium Generic | 81 | 237 | 24 | $595 |
| Pantoprazole Sodium Generic | 78 | 235 | 26 | $1,282 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 77 | 221 | 25 | $2,938 |
| Metformin Hcl Generic | 77 | 236 | 26 | $556 |
Brand drugs: 809 claims; generic drugs: 4,231 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rosalo M Paeste $1,893 ($1,893 in general payments such as food, travel and fees) from 13 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $389.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $389 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $268 |
| Amgen Inc. AMGN | 4 | $205 |
| Novo Nordisk Inc NVO | 3 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $165 |
| Gilead Sciences, Inc. GILD | 6 | $162 |
| Lilly USA, LLC LLY | 2 | $128 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $125 |
| Pfizer Inc. PFE | 1 | $121 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $57.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.